Different reports have described that FGF15 acts in the brain of rodent models of obesity and enhances insulin sensitivity, improves glucose tolerance, decreases food intake and body weight, and increases energy expenditure (180, 181, 182, 183). This evidence concerns the gene INS and obesity disorder.